Cocrystal Pharma (COCP) Receivables - Net (2010 - 2020)
Cocrystal Pharma (COCP) posted Receivables - Net of $556000.0 for Q4 2020, down 4.3% sequentially from $581000.0 in Q3 2020, and down 13.66% YoY from $644000.0 in Q1 2020.
Cocrystal Pharma (COCP) Receivables - Net (2010 - 2020) Analysis & Trends
Cocrystal Pharma has reported Receivables - Net for 10 years, with the latest figure at $556000.0 in Q4 2020.
- Quarterly Receivables - Net fell 13.66% year-over-year to $556000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $556000.0 (down 13.66% YoY) and the FY2020 annual result came in at $556000.0, down 13.66% from the prior year.
- Receivables - Net eased to $556000.0 in Q4 2020 per COCP's latest filing, from $581000.0 in the prior quarter.
- Over five years, Receivables - Net peaked at $1.1 million in Q1 2019 and troughed at $1000.0 in Q4 2017.
- A 4-year average of $449538.5 and a median of $581000.0 in 2020 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2016 and 2017: Receivables - Net soared 33.33% in 2016, then plunged 95.24% in 2017.
- Over 4 years, Receivables - Net stood at $21000.0 in 2016, then slumped by 95.24% to $1000.0 in 2017, then soared by 64300.0% to $644000.0 in 2019, then declined by 13.66% to $556000.0 in 2020.
- According to Business Quant data, Receivables - Net over the past three periods registered $556000.0, $581000.0, and $592000.0 for Q4 2020, Q3 2020, and Q2 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.59 Bn | 131.73 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.21 Bn | 78.22 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.65 Bn | 60.47 Bn | 1.37 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Cocrystal Pharma | 16.13 Mn | 13.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 556,000.00 |
| Dec 31, 2020 | 556,000.00 |
| Sep 30, 2020 | 581,000.00 |
| Sep 30, 2020 | 581,000.00 |
| Jun 30, 2020 | 592,000.00 |
| Jun 30, 2020 | 592,000.00 |
| Mar 31, 2020 | 644,000.00 |
| Mar 31, 2020 | 644,000.00 |
| Dec 31, 2019 | 644,000.00 |
| Dec 31, 2019 | 644,000.00 |
| Sep 30, 2019 | 768,000.00 |
| Sep 30, 2019 | 768,000.00 |
| Jun 30, 2019 | 914,000.00 |
| Jun 30, 2019 | 914,000.00 |
| Mar 31, 2019 | 1.08 Mn |
| Mar 31, 2019 | 1.08 Mn |
| Dec 31, 2017 | 1,000.00 |
| Dec 31, 2017 | 1,000.00 |
| Dec 31, 2016 | 21,000.00 |
| Dec 31, 2016 | 21,000.00 |